The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive molecular characterization of thymic epithelial tumors.
 
Chul Kim
Consulting or Advisory Role - Arcus Biosciences; AstraZeneca; Daiichi Sankyo; Eisai; Janssen; Jazz Pharmaceuticals; Regeneron; Sanofi
Research Funding - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; Janssen; Karyopharm Therapeutics; Lyell Immunopharma; Novartis; Regeneron
 
Tolulope Tosin Adeyelu
Employment - Caris Life Sciences
 
Rohan Maniar
No Relationships to Disclose
 
Alex Patrick Farrell
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Jacob Peter Zaemes
Consulting or Advisory Role - MJH Life Sciences
 
Jeffrey Peter Solzak
Employment - Caris Life Sciences
 
Bradley Allen Hancock
Employment - Caris Life Sciences; Lifeomic LLC
Stock and Other Ownership Interests - Lifeomic LLC
 
Andrew Elliott
Employment - Caris Life Sciences
 
Ida Micaily
No Relationships to Disclose
 
Misako Nagasaka
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo; EMD Serono; Genentech; Janssen; Lilly; Mirati Therapeutics; Novartis; Pfizer; Takeda
Speakers' Bureau - Blueprint Medicines; Janssen; Mirati Therapeutics; Mirati Therapeutics; Takeda
Research Funding - Tempus
Travel, Accommodations, Expenses - Anheart Therapeutics
 
Jorge J. Nieva
Stock and Other Ownership Interests - Cansera; Epic Sciences; Indee P/L
Consulting or Advisory Role - AADi; ANP Technologies; AstraZeneca; Bioatla; Mindmed
Research Funding - Genentech (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending - movement and unexpected healthcare encounters
 
Hossein Borghaei
Stock and Other Ownership Interests - Nucleai; Rgenix; Sonnet
Honoraria - Amgen; Axiom Biotechnologies; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/UCB Japan; Pfizer; Regeneron
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bayer; Beigene; BerGenBio; BioNTech; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Genentech; Genmab; Guardant Health; IO Biotech; ITeos Therapeutics; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Mirati Therapeutics; natera; Novartis; oncocyte; Pfizer; PharmaMar; Puma Biotechnology; Regeneron; Rgenix; Sonnet; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Clovis Oncology; EMD Serono; Genentech; Lilly; Merck; Novartis; Regeneron
Other Relationship - Incyte; Novartis; SpringWorks Therapeutics; Takeda; University of Pennsylvania
 
Balazs Halmos
Consulting or Advisory Role - Apollomics; Arcus Biosciences; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Genentech/Roche; Janssen Oncology; Lilly; Merck; merus; Novartis; Pfizer; Takeda; Turning Point Therapeutics; Veracyte
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen; AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Elevation Oncology (Inst); Forward (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Takeda (Inst); Tesaro/GSK (Inst)
 
Patrick C. Ma
Honoraria - AstraZeneca; BeiGene
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Elevation Oncology (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); OncoC4 (Inst); Roche/Genentech (Inst)
 
Milan Radovich
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - LifeOmic
Patents, Royalties, Other Intellectual Property - Patents developed at Caris Life Sciences (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Sunil S Badve
Honoraria - Bristol Myers Squibb Foundation; Dako/Agilent Technologies; Personalis; Ventana Medical Systems
Consulting or Advisory Role - Agilent; BMS; PAIGE.AI; Ventana Medical Systems
Speakers' Bureau - Agilent; Genomic Health; Targos GmbH
Research Funding - Bristol Myers Squibb Foundation (Inst); Dako/Agilent Technologies (Inst); Lilly (Inst)
Patents, Royalties, Other Intellectual Property - E-Score for predicting recurrence of DCIS (Inst); EarlyR - signature for ER+ breast cancer (Inst)
 
Patrick J. Loehrer
Research Funding - Lilly Foundation (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - US PPA/61/499,988 Gene Expression Analysis of Thymic Neoplasms Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick Loehrer (Inst)
Other Relationship - National Cancer Institute